Lyell Immunopharma
LYEL
#8283
Rank
$0.17 B
Marketcap
$0.59
Share price
-7.90%
Change (1 day)
-69.49%
Change (1 year)

Lyell Immunopharma (LYEL) - P/B ratio

P/B ratio as of December 2024 : 0.3275

According to Lyell Immunopharma's latest financial reports the company has a price-to-book ratio of 2758.84.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.

Lyell Immunopharma - P/B ratio (from 2021 to 2024)

P/B ratio by year

Year P/B ratio Change
2024-12-310.4148-44.41%
2023-12-310.7460-28.15%
2022-12-311.04-48.13%
2021-12-312.00
2020-12-31N/A